Target intelligence / Profile preview

Eukaryotic translation initiation factor (with specific subtypes: eIF4E, eIF4G, eIF2, etc.) (eIF (for the family); commonly used forms include eIF4E, eIF4G, eIF2, eIF3, etc.)

Target
eIF (for the family); commonly used forms include eIF4E, eIF4G, eIF2, eIF3, etc.
Molecular classification
Enzyme (some, e.g., GTPase activity: eIF2), Adapter protein (e.g., eIF4G), RNA helicase (eIF4A), Cap-binding protein (eIF4E, eIF3d), RNA-binding protein
01

Overview

Eukaryotic translation initiation factors are essential proteins required to initiate the translation of messenger RNA into protein in eukaryotic organisms. They regulate the recruitment and positioning of ribosomes, the initiator tRNA, and mRNA at the correct start codon, enabling the assembly of elongation-competent ribosomes and the beginning of protein synthesis. These factors are tightly regulated, often through phosphorylation and protein-protein interactions, and represent critical control points for overall gene expression. Abnormal activity or regulation of these factors is linked to diseases such as cancer and infection, and their modulation is a promising therapeutic strategy

Other names
Translation initiation factoreIF (often with a number or letter, e.g., eIF4E, eIF2, eIF4G)Initiation factor (generic)
02

Mechanism of action

Inhibition of cap-dependent translation initiation (anticancer/antiviral, e.g., by targeting eIF4E, eIF4A); Disruption of eIF4E/eIF4G interaction; Modulation of eIF2 phosphorylation to affect integrated stress response; Promotion or inhibition of ribosome assembly at mRNA

03

Biological functions

Protein synthesis (translation initiation)Gene expression regulationCell growth and proliferationCellular response to stressHomeostasis and adaptationPathogenesis and infection (host-pathogen interaction)
04

Disease associations

Cancer (abnormal eIF expression/protein synthesis)Infection (targeted by viruses to shutoff host protein synthesis)Neurodegenerative diseaseOther: cell proliferation/dysregulation
05

Safety considerations

Broad inhibition may affect normal cell growth and tissue homeostasisMyelosuppression, gastrointestinal symptoms, neurological toxicity (for inhibitors disrupting global translation)Relapse due to compensatory translation mechanismsPotential for off-target effects due to ubiquity of translation process
06

Interacting drugs

Silvestrol, Rocaglamide (target eIF4A in cancer therapy; block cap-dependent translation)

3 more in the full profile.

07

Biomarkers

Overexpression or phosphorylation state of eIF4E (cancer biomarker)Levels of eIF2α phosphorylation (stress response and neurodegeneration)Expression of specific eIF family members in tumor or infected tissue

Beyond the preview

Go deeper on Eukaryotic translation initiation factor (with specific subtypes: eIF4E, eIF4G, eIF2, etc.) (eIF (for the family); commonly used forms include eIF4E, eIF4G, eIF2, eIF3, etc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor (with specific subtypes: eIF4E, eIF4G, eIF2, etc.) (eIF (for the family); commonly used forms include eIF4E, eIF4G, eIF2, eIF3, etc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call